Westfield Capital Management’s Fate Therapeutics FATE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-1,386,058
| Closed | -$14M | – | 235 |
|
|
2022
Q4 | $14M | Sell |
1,386,058
-5,159
| -0.4% | -$52.1K | 0.11% | 168 |
|
|
2022
Q3 | $31.2M | Sell |
1,391,217
-403,031
| -22% | -$9.03M | 0.25% | 142 |
|
|
2022
Q2 | $44.5M | Buy |
1,794,248
+573,927
| +47% | +$14.2M | 0.35% | 101 |
|
|
2022
Q1 | $47.3M | Buy |
1,220,321
+740,673
| +154% | +$28.7M | 0.3% | 117 |
|
|
2021
Q4 | $28.1M | Buy |
479,648
+188,547
| +65% | +$11M | 0.17% | 154 |
|
|
2021
Q3 | $17.3M | Sell |
291,101
-10,550
| -3% | -$625K | 0.1% | 174 |
|
|
2021
Q2 | $26.2M | Buy |
301,651
+44,934
| +18% | +$3.9M | 0.16% | 167 |
|
|
2021
Q1 | $21.2M | Buy |
256,717
+97,078
| +61% | +$8M | 0.13% | 172 |
|
|
2020
Q4 | $14.5M | Sell |
159,639
-250,690
| -61% | -$22.8M | 0.09% | 183 |
|
|
2020
Q3 | $16.4M | Sell |
410,329
-27,994
| -6% | -$1.12M | 0.11% | 177 |
|
|
2020
Q2 | $15M | Buy |
438,323
+26,227
| +6% | +$900K | 0.1% | 184 |
|
|
2020
Q1 | $9.15M | Sell |
412,096
-292,747
| -42% | -$6.5M | 0.08% | 178 |
|
|
2019
Q4 | $13.8M | Sell |
704,843
-200,776
| -22% | -$3.93M | 0.1% | 178 |
|
|
2019
Q3 | $14.1M | Buy |
905,619
+46,870
| +5% | +$728K | 0.11% | 174 |
|
|
2019
Q2 | $17.4M | Sell |
858,749
-34,676
| -4% | -$704K | 0.13% | 182 |
|
|
2019
Q1 | $15.7M | Sell |
893,425
-210,880
| -19% | -$3.71M | 0.12% | 187 |
|
|
2018
Q4 | $14.2M | Buy |
1,104,305
+272,235
| +33% | +$3.49M | 0.12% | 177 |
|
|
2018
Q3 | $13.6M | Buy |
832,070
+26,610
| +3% | +$433K | 0.1% | 191 |
|
|
2018
Q2 | $9.13M | Buy |
+805,460
| New | +$9.13M | 0.07% | 205 |
|